N <sup>6</sup> ‐Methyladenosine‐Modified CBX1 Regulates Nasopharyngeal Carcinoma Progression Through Heterochromatin Formation and STAT1 Activation-Reference-Cited by-同舟云学术

N ⁶ ‐Methyladenosine‐Modified CBX1 Regulates Nasopharyngeal Carcinoma Progression Through Heterochromatin Formation and STAT1 Activation

Published:2022-10-30 Issue:36 Volume:9 Page:
ISSN:2198-3844
Container-title:Advanced Science
language:en
Short-container-title:Advanced Science

Author:

Zhao Yin¹^ORCID,Huang Shengyan¹,Tan Xirong¹,Long Liufen¹,He Qingmei¹,Liang Xiaoyu¹,Bai Jiewen¹,Li Qingjie¹,Lin Jiayi¹,Li Yingqin¹,Liu Na¹,Ma Jun¹^ORCID,Chen Yupei¹^ORCID

Affiliation:

1. Sun Yat‐sen University Cancer Center State Key Laboratory of Oncology in South China Collaborative Innovation Center of Cancer Medicine Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy 651 Dongfeng Road East Guangzhou Guangdong 510060 China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Guangdong Province

Overseas Expertise Introduction Project for Discipline Innovation

Publisher

Wiley

Subject

General Physics and Astronomy,General Engineering,Biochemistry, Genetics and Molecular Biology (miscellaneous),General Materials Science,General Chemical Engineering,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/advs.202205091

Reference74 articles.

1. Nasopharyngeal carcinoma

2. Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline

3. Nasopharyngeal carcinoma: an evolving paradigm

4. The expanding universe of checkpoint inhibitors for nasopharyngeal cancer

5. Comparative safety and efficacy of anti-PD-1 monotherapy, chemotherapy alone, and their combination therapy in advanced nasopharyngeal carcinoma: findings from recent advances in landmark trials

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DCAF7 Acts as A Scaffold to Recruit USP10 for G3BP1 Deubiquitylation and Facilitates Chemoresistance and Metastasis in Nasopharyngeal Carcinoma;Advanced Science;2024-07-08

2. PJA1-mediated suppression of pyroptosis as a driver of docetaxel resistance in nasopharyngeal carcinoma;Nature Communications;2024-06-21

3. CBX1 is involved in hepatocellular carcinoma progression and resistance to sorafenib and lenvatinib via IGF-1R/AKT/SNAIL signaling pathway;Hepatology International;2024-05-20

4. Role of m6A modifications in immune evasion and immunotherapy;Medical Oncology;2024-05-18

5. Transcription factor ATMIN facilitates chemoresistance in nasopharyngeal carcinoma;Cell Death & Disease;2024-02-06